Li Wenze, Cai Jiajia, Ding Liqin, Chen Yanyan, Wang Xiaoqin, Xu Hongyan
Department of Psychiatric Geriatric Intensive Care Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China.
Nursing Department, Tongde Hospital of Zhejiang Province, Hangzhou, China.
J Thorac Dis. 2024 Sep 30;16(9):5518-5528. doi: 10.21037/jtd-24-150. Epub 2024 Sep 14.
Ventilator-associated pneumonia (VAP) is a serious complication occurring in critically ill patients receiving mechanical ventilation in the intensive care unit (ICU). This study attempted to analyze VAP incidence in the ICU using a meta-analysis, investigate risk factors for VAP occurrence, and examine influence of VAP on outcomes.
A search was carried out in the Web of Science, PubMed, Embase, and The Cochrane Library databases to identify studies on incidence and risk factors of VAP in ICU patients. Study quality was tested by the Newcastle-Ottawa Scale. Data related to risk factors, incidence, and outcomes were utilized for meta-analysis. Meta-analysis was conducted using Stata 18 and Review Manager 5.4.
Seventeen articles were included, comprising 6,222 patients, and incidence of VAP was 30% [95% confidence interval (CI): 24-37%]. Risk factor analysis showed that males [odds ratio (OR): 1.50; 95% CI: 1.29-1.75; P<0.001], smoking (OR: 1.30; 95% CI: 1.08-1.57; P=0.007) and Acute Physiology and Chronic Health Evaluation II (APACHE II) score [weighted mean difference (WMD): 1.30; 95% CI: 0.31-2.30; P=0.01] were risk factors for VAP. Antibiotic prophylaxis (OR: 0.79; 95% CI: 0.63-0.99; P=0.04) was a protect factor for VAP. Compared with non-VAP patients, VAP patients had a prolonged duration of mechanical ventilation (WMD: 6.96; 95% CI: 5.42-8.50; P<0.001), ICU length of stay (WMD: 7.91; 95% CI: 5.43-10.39; P<0.001) and total length of hospital stay (WMD: 8.09; 95% CI: 3.70-12.48; P=0.0003). There was no significant difference in mortality rate between VAP and non-VAP patients (OR: 1.13; 95% CI: 0.79-1.63; P=0.50).
VAP incidence in the ICU was around 30%. Male, smoking, and high APACHE II score were risk factors for VAP, while antibiotic prophylaxis was a protective factor for VAP. VAP could lead to prolonged mechanical ventilation, ICU stay, and hospital stay, but it did not influence mortality.
呼吸机相关性肺炎(VAP)是重症监护病房(ICU)中接受机械通气的重症患者发生的一种严重并发症。本研究试图通过荟萃分析来分析ICU中VAP的发生率,调查VAP发生的危险因素,并研究VAP对结局的影响。
在Web of Science、PubMed、Embase和Cochrane图书馆数据库中进行检索,以确定关于ICU患者VAP发生率和危险因素的研究。采用纽卡斯尔-渥太华量表对研究质量进行评估。将与危险因素、发生率和结局相关的数据用于荟萃分析。使用Stata 18和Review Manager 5.4进行荟萃分析。
纳入17篇文章,共6222例患者,VAP发生率为30%[95%置信区间(CI):24%-37%]。危险因素分析显示,男性[比值比(OR):1.50;95%CI:1.29-1.75;P<0.001]、吸烟(OR:1.30;95%CI:1.08-1.57;P=0.007)和急性生理与慢性健康状况评分II(APACHE II)[加权均数差(WMD):1.30;95%CI:0.31-2.30;P=0.01]是VAP的危险因素。抗生素预防(OR:0.79;95%CI:0.63-0.99;P=0.04)是VAP的保护因素。与非VAP患者相比,VAP患者机械通气时间延长(WMD:6.96;95%CI:5.42-8.50;P<0.001)、ICU住院时间延长(WMD:7.91;95%CI:5.43-10.39;P<0.001)和总住院时间延长(WMD:8.09;95%CI:3.70-12.48;P=0.0003)。VAP患者和非VAP患者的死亡率无显著差异(OR:1.13;95%CI:0.79-1.63;P=0.50)。
ICU中VAP的发生率约为30%。男性、吸烟和高APACHE II评分是VAP的危险因素,而抗生素预防是VAP的保护因素。VAP可导致机械通气时间、ICU住院时间和住院时间延长,但不影响死亡率。